Targeted Genetics completes Genovo acquisition

Gene therapy play TGEN completed its previously announced acquisition of Genovo (Sharon Hill, Penn.) for 6.6 million TGEN shares, or $84.5 million based on TGEN's Tuesday close at $12.75. Genovo is de...